<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1110</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2018-17-1-28-33</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Natural history of papillomaviruses in men – what is known?</article-title><trans-title-group xml:lang="ru"><trans-title>Естественная циркуляция вирусов папилломы человека у мужчин – что о ней известно?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Volgareva</surname><given-names>G. M.</given-names></name><name xml:lang="ru"><surname>Волгарева</surname><given-names>Г. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p><p>Галина Михайловна Волгарева</p></bio><email>galina.volgareva@ronc.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-02-27" publication-format="electronic"><day>27</day><month>02</month><year>2018</year></pub-date><volume>17</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>28</fpage><lpage>33</lpage><history><date date-type="received" iso-8601-date="2018-11-26"><day>26</day><month>11</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-11-26"><day>26</day><month>11</month><year>2018</year></date></history><permissions><copyright-year>2018</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/1110">https://bioterapevt.abvpress.ru/jour/article/view/1110</self-uri><abstract xml:lang="en"><p>Up till now human papillomaviruses (HPV) draw attention of biologists and clinicians owing mostly to the fact that some members of this group cause cervical cancer in women. However it is clear that both women and men take part in HPV distribution throughout population. Data get accumulated on peculiarities of HPV natural history in men when compared with women, as well as on capability of oncogenic HPV to induce cancer in several male organs. The present paper is an attempt to synthesize literature data on specific features of HPV natural history in men. Elucidation of these features is important for working out efficient approaches for prevention of HPV-associated malformation with regard to gender specificities.</p></abstract><trans-abstract xml:lang="ru"><p>Вирусы папилломы человека (ВПЧ) до настоящего времени привлекают к себе внимание биологов и врачей в первую очередь в связи с тем, что ряд представителей этой группы вызывают рак шейки матки у женщин. Вместе с тем очевидно, что в циркуляции этих вирусов в популяции участвуют как женщины, так и мужчины. Накапливаются данные о том, что имеется ряд особенностей в распространении ВПЧ среди мужчин по сравнению с женщинами, а также о том, что онкогенные ВПЧ вызывают рак в некоторых органах и у мужчин. Настоящая работа представляет собой попытку обобщения данных литературы об особенностях распространения ВПЧ у мужчин. Уяснение этих различий важно для разработки эффективных мер профилактики ВПЧ-ассоциированных новообразований с учетом гендерных особенностей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>human papillomaviruses</kwd><kwd>natural history</kwd><kwd>men</kwd><kwd>cancer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирусы папилломы человека</kwd><kwd>естественная циркуляция</kwd><kwd>мужчины</kwd><kwd>рак</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. zur Hausen H. Papillomaviruses in the causation of human cancer – a brief historical account. Virology 2009;384(2):260–5. DOI: 10.1016/j.virol.2008.11.046. PMID: 19135222.</mixed-citation><mixed-citation xml:lang="ru">zur Hausen H. Papillomaviruses in the causation of human cancer – a brief historical account. Virology 2009;384(2):260–5. DOI: 10.1016/j.virol.2008.11.046. PMID: 19135222.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36(2 Pt 2):794. PMID: 175942.</mixed-citation><mixed-citation xml:lang="ru">zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36(2 Pt 2):794. PMID: 175942.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Durst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80(12):3812–5. PMID: 6304740.</mixed-citation><mixed-citation xml:lang="ru">Durst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80(12):3812–5. PMID: 6304740.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Schwarz E., Freese U.K., Gissmann L. et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314(6006): 111–4. PMID: 2983228.</mixed-citation><mixed-citation xml:lang="ru">Schwarz E., Freese U.K., Gissmann L. et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314(6006): 111–4. PMID: 2983228.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. zur Hauzen H. Papillomaviruses causing cancer: evasiom from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92(9):690–8. PMID: 10793105.</mixed-citation><mixed-citation xml:lang="ru">zur Hauzen H. Papillomaviruses causing cancer: evasiom from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92(9):690–8. PMID: 10793105.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. zur Hauzen H. Papillomaviruses – to vaccination and beyond. Biochemistry 2008;73(5):498–505. DOI: 10.1134/S0006297908050027. PMID: 18605974.</mixed-citation><mixed-citation xml:lang="ru">zur Hauzen H. Papillomaviruses – to vaccination and beyond. Biochemistry 2008;73(5):498–505. DOI: 10.1134/S0006297908050027. PMID: 18605974.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. de Villiers E.M. Cross-roads in the classification of papillomaviruses. Virology 2013;445(1–2):2–10. DOI: 10.1016/j.virol.2013.04.023. PMID: 23683837.</mixed-citation><mixed-citation xml:lang="ru">de Villiers E.M. Cross-roads in the classification of papillomaviruses. Virology 2013;445(1–2):2–10. DOI: 10.1016/j.virol.2013.04.023. PMID: 23683837.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Bernard H.U., Burk R.D., Chen Z. et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010;401(1):70–9. DOI: 10.1016/j.virol.2010.02.002. PMID: 20206957.</mixed-citation><mixed-citation xml:lang="ru">Bernard H.U., Burk R.D., Chen Z. et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010;401(1):70–9. DOI: 10.1016/j.virol.2010.02.002. PMID: 20206957.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human Papillomaviruses. Lyon, 1995.</mixed-citation><mixed-citation xml:lang="ru">IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human Papillomaviruses. Lyon, 1995.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 90. Human Papillomaviruses. Lyon, 2007.</mixed-citation><mixed-citation xml:lang="ru">IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 90. Human Papillomaviruses. Lyon, 2007.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 100. A review of human carcinogens. Part B. Biological agents. Lyon, 2011.</mixed-citation><mixed-citation xml:lang="ru">IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 100. A review of human carcinogens. Part B. Biological agents. Lyon, 2011.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Giuliano A.R., Nyitray A.G., Kreimer A.R. et al. EUROGIN 2014 Roadmap: differences in HPV infection natural history, transmission, and HPV-related cancer incidence by gender and anatomic site of infection. Int J Cancer 2015;136(12):2752–60. DOI: 10.1002/ijc.29082. PMID: 25043222.</mixed-citation><mixed-citation xml:lang="ru">Giuliano A.R., Nyitray A.G., Kreimer A.R. et al. EUROGIN 2014 Roadmap: differences in HPV infection natural history, transmission, and HPV-related cancer incidence by gender and anatomic site of infection. Int J Cancer 2015;136(12):2752–60. DOI: 10.1002/ijc.29082. PMID: 25043222.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Hartwig S., Syrjanen S., Dominiak-Felden G. et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012;12:30. DOI: 10.1186/1471-2407-12-30. PMID: 22260541.</mixed-citation><mixed-citation xml:lang="ru">Hartwig S., Syrjanen S., Dominiak-Felden G. et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012;12:30. DOI: 10.1186/1471-2407-12-30. PMID: 22260541.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. de Martel C., Ferlay J., Franceschi S. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13(6):607–15. DOI: 10.1016/S1470-2045(12)70137-7. PMID: 22575588.</mixed-citation><mixed-citation xml:lang="ru">de Martel C., Ferlay J., Franceschi S. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13(6):607–15. DOI: 10.1016/S1470-2045(12)70137-7. PMID: 22575588.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Gillison M.L., Broutian T., Pickard R.K. et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 2012;307(7):693-703. DOI: 10.1001/jama.2012.101. PMID: 22282321.</mixed-citation><mixed-citation xml:lang="ru">Gillison M.L., Broutian T., Pickard R.K. et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 2012;307(7):693-703. DOI: 10.1001/jama.2012.101. PMID: 22282321.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Kreimer A.R., Pierce Campbell C.M., Lin H.-Y. et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 2013;382(9895):877–87. DOI: 10.1016/S0140-6736(13)60809-0. PMID: 23827089.</mixed-citation><mixed-citation xml:lang="ru">Kreimer A.R., Pierce Campbell C.M., Lin H.-Y. et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 2013;382(9895):877–87. DOI: 10.1016/S0140-6736(13)60809-0. PMID: 23827089.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Pierce Campbell C.M., Kreimer A.R., Lin H.-Y. et al. Long-term persistence of oral human papillomavirus type 16: The HPV Infection in Men (HIM) study. Cancer Prev Res (Phila) 2015;8(3):190–6. DOI: 10.1158/1940-6207.CAPR-14-0296. PMID: 25575501.</mixed-citation><mixed-citation xml:lang="ru">Pierce Campbell C.M., Kreimer A.R., Lin H.-Y. et al. Long-term persistence of oral human papillomavirus type 16: The HPV Infection in Men (HIM) study. Cancer Prev Res (Phila) 2015;8(3):190–6. DOI: 10.1158/1940-6207.CAPR-14-0296. PMID: 25575501.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Nyitray A.G., Carvalho da Silva R.J., Baggio M.L. et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: The HPV in Men (HIM) study. J Infect Dis 2011;203(1):49–57. DOI: 10.1093/infdis/jiq021. PMID: 21148496.</mixed-citation><mixed-citation xml:lang="ru">Nyitray A.G., Carvalho da Silva R.J., Baggio M.L. et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: The HPV in Men (HIM) study. J Infect Dis 2011;203(1):49–57. DOI: 10.1093/infdis/jiq021. PMID: 21148496.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Sichero L., Nyitray A.G., Nunes E.M. et al. Diversity of human papillomavirus in the anal canal of men: The HIM study. Clin Microbiol Infect 2015;21(5):502–9. DOI: 10.1016/j.cmi.2014.12.023. PMID: 25698660.</mixed-citation><mixed-citation xml:lang="ru">Sichero L., Nyitray A.G., Nunes E.M. et al. Diversity of human papillomavirus in the anal canal of men: The HIM study. Clin Microbiol Infect 2015;21(5):502–9. DOI: 10.1016/j.cmi.2014.12.023. PMID: 25698660.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Nyitray A.G., Carvalho da Silva R.J., Baggio M.L. et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011;204(11):1711–22. DOI: 10.1093/infdis/jir637. PMID: 21964400.</mixed-citation><mixed-citation xml:lang="ru">Nyitray A.G., Carvalho da Silva R.J., Baggio M.L. et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011;204(11):1711–22. DOI: 10.1093/infdis/jir637. PMID: 21964400.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Giuliano A.R., Lazcano-Ponce E., Villa L.L. et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17(8): 2036–43. DOI: 10.1158/1055-9965. PMID: 18708396.</mixed-citation><mixed-citation xml:lang="ru">Giuliano A.R., Lazcano-Ponce E., Villa L.L. et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17(8): 2036–43. DOI: 10.1158/1055-9965. PMID: 18708396.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Dunne E.F., Unger E.R., Sternberg M. et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297(8):813–9. DOI: 10.1001/jama.297.8.813. PMID: 17327523.</mixed-citation><mixed-citation xml:lang="ru">Dunne E.F., Unger E.R., Sternberg M. et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297(8):813–9. DOI: 10.1001/jama.297.8.813. PMID: 17327523.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Giuliano A.R., Lee J.H., Fulp W. et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377(9769):932–40. DOI: 10.1016/S0140-6736(10)62342-2. PMID: 21367446.</mixed-citation><mixed-citation xml:lang="ru">Giuliano A.R., Lee J.H., Fulp W. et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377(9769):932–40. DOI: 10.1016/S0140-6736(10)62342-2. PMID: 21367446.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Sichero L., Pierce Campbell C.M., Ferreira S. et al. Broad HPV distribution in the genital region of men from the HPV infection in men (HIM) study. Virology 2013;443 (2):214–7. DOI: 10.1016/j.virol.2013.04.024. PMID: 23722104.</mixed-citation><mixed-citation xml:lang="ru">Sichero L., Pierce Campbell C.M., Ferreira S. et al. Broad HPV distribution in the genital region of men from the HPV infection in men (HIM) study. Virology 2013;443 (2):214–7. DOI: 10.1016/j.virol.2013.04.024. PMID: 23722104.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Sichero L., Pierce Campbell C.M., Ferreira S. et al. High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study. BMC Infect Dis 2014;14:677. DOI: 10.1186/s12879-014-0677-y. PMID: 25857319.</mixed-citation><mixed-citation xml:lang="ru">Sichero L., Pierce Campbell C.M., Ferreira S. et al. High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study. BMC Infect Dis 2014;14:677. DOI: 10.1186/s12879-014-0677-y. PMID: 25857319.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Morrison C., Catania F., Wakely P.Jr., Nuovo G.J. Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions. Am J Surg Pathol 2001;25(10):1310–5. PMID: 11688467.</mixed-citation><mixed-citation xml:lang="ru">Morrison C., Catania F., Wakely P.Jr., Nuovo G.J. Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions. Am J Surg Pathol 2001;25(10):1310–5. PMID: 11688467.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Grulich A.E., Poynten I.M., Machalek D.A. et al. The epidemiology of anal cancer. Sex Health 2012;9(6):504–8. DOI: 10.1071/SH12070. PMID: 22958581.</mixed-citation><mixed-citation xml:lang="ru">Grulich A.E., Poynten I.M., Machalek D.A. et al. The epidemiology of anal cancer. Sex Health 2012;9(6):504–8. DOI: 10.1071/SH12070. PMID: 22958581.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Chaturvedi A.K. Epidemiology and clinical aspects of HPV in head and neck cancers. Head and Neck Pathol 2012;6(Suppl 1):S16–24. DOI: 10.1007/s12105-012-0377-0. PMID: 22782220.</mixed-citation><mixed-citation xml:lang="ru">Chaturvedi A.K. Epidemiology and clinical aspects of HPV in head and neck cancers. Head and Neck Pathol 2012;6(Suppl 1):S16–24. DOI: 10.1007/s12105-012-0377-0. PMID: 22782220.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Давыдов М.М., Аксель Е.М. Стандартизованные показатели онкоэпидемиологической ситуации 2015 г. Россия. Евразийский онкологический журнал 2017;5(2):298–317.</mixed-citation><mixed-citation xml:lang="ru">Давыдов М.М., Аксель Е.М. Стандартизованные показатели онкоэпидемиологической ситуации 2015 г. Россия. Евразийский онкологический журнал 2017;5(2):298–317.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Reiter P.L., Pendergraft W.F. 3rd, Brewer N.T. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev 2010;19(11):2916–31. DOI: 10.1158/1055-9965.EPI-10-0576. PMID: 20833971.</mixed-citation><mixed-citation xml:lang="ru">Reiter P.L., Pendergraft W.F. 3rd, Brewer N.T. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev 2010;19(11):2916–31. DOI: 10.1158/1055-9965.EPI-10-0576. PMID: 20833971.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Dodd R.H., McCaffery K.J., Marlow L.A. et al. Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey. Sex Transm Infect 2014;90(3):201–7. DOI: 10.1136/sextrans-2013-051402. PMID: 24412997.</mixed-citation><mixed-citation xml:lang="ru">Dodd R.H., McCaffery K.J., Marlow L.A. et al. Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey. Sex Transm Infect 2014;90(3):201–7. DOI: 10.1136/sextrans-2013-051402. PMID: 24412997.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
